RT Journal Article SR Electronic T1 DIBENAMINE IMPAIRMENT OF RAT HEPATIC MICROSOMAL ENZYMES AND ITS RELATION TO HEPATOTOXICITY INDUCED BY CCl4 AND DIMETHYLNITROSAMINE JF Drug Metabolism and Disposition JO Drug Metab Dispos FD American Society for Pharmacology and Experimental Therapeutics SP 464 OP 468 VO 2 IS 5 A1 BITTEN STRIPP A1 I. GLENN SIPES A1 HARRIET M. MALING A1 JAMES R. GILLETTE YR 1974 UL http://dmd.aspetjournals.org/content/2/5/464.abstract AB Pretreatment of rats with dibenamine ·HCl (25 mg/kg sc 48 and 24 hr before death) decreased the activity of cytochrome P-450-dependent enzymes in hepatic microsomes as judged by the in vitro N-demethylation of ethylmorphine and dimethylnitrosamine and covalent binding of 14CCI4 and 14C-dimethylnitrosamine. The decrease in enzymatic activity is probably not due solely to a decrease in the amount of cytochrome P-450. Dibenamine pretreatment may protect rats from the hepatotoxicity of CCl4 or dimethylnitrosamine by reducing the formation of active metabolites by microsomal enzymes. Copyright © 1974 by The American Society for Pharmacology and Experimental Therapeutics